Fundraising Fox
/Companies
Sign in

Helex

Founded 2021 · 35 employees on LinkedIn · 4 known investors

Find your way into Helex

Sign up to see every warm intro you have to Helex

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Helex team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Helex is a biotech company whose team specializes in molecular biology, drug delivery, biomedical engineering, and nanotechnology research.

BiotechDigital Health

Founders & leadership

Helex was founded in 2021 by Rohini Kalvakuntla.

RKRohini Kalvakuntla
Rohini KalvakuntlaCo-Founder and Chief Business OfficerFounder of Helex, a biotech company focused on molecular biology, drug delivery, biomedical engineering, and nanotechnology research.

Investors · 4

SOSVlisted by SOSVNew York · $30K – $550K

How we know: m.economictimes.com · funding news · open dataset · 5k.vc investor directory · sosv.com · Not right? Tell us

IndieBioreportedSan Francisco · $525K

How we know: open dataset · 5k.vc investor directory · Not right? Tell us

Also in the syndicate · 1

Bluehill Capital

Funding

SEC filings, press & company announcements

$3.5M disclosed across 1 of 2 rounds · 2025

Source: company announcements and press reports — follow each round's link for the claim.

Related companies · 6

HelixHelix is a population genomics company that provides an end-to-end platform to integrate genomic data into clinical care, research, and therapeutic development. It partners with health systems, providers, payers, life sciences organizations, and patients to enable genetic screening and personalized healthcare at scale.
Lexicon PharmaceuticalsLexicon Pharmaceuticals develops and commercializes pharmaceutical products, including the marketed drug INPEFA and drug candidates in clinical development such as sotagliflozin, pilavapadin, and LX9851, serving patients in need of treatments across various therapeutic areas.
Helix BiomedixHelix BioMedix is a publicly traded company (OTCMKTS: HXBM). The stock information page provides investor relations and transfer agent details but does not describe the company's products or business activities.
ExelixisExelixis is an oncology company that discovers and develops cancer treatments, including small molecule therapeutics and biotherapeutics such as antibody-drug conjugates, for patients across multiple tumor types. Its flagship commercial product is CABOMETYX (cabozantinib), and it operates through global development and commercialization partnerships.
HealxHealx uses artificial intelligence to redevelop, combine, and enhance known compounds to build a pipeline of therapies for rare diseases, with an expanding focus on oncology and preventing cancer recurrence. The company runs multiple drug discovery programmes in parallel, bringing candidate treatments from prediction through clinical trials.
LexeotxLexeo is a clinical-stage genetic medicine company developing gene therapies that target the genetic causes of cardiovascular diseases. Based in New York City, it focuses on treatments for heart health and other genetic diseases regardless of prevalence.

Companies working in the same space as Helex.

Frequently asked questions

What does Helex do?
Helex is a biotech company whose team specializes in molecular biology, drug delivery, biomedical engineering, and nanotechnology research.
Who founded Helex?
Helex was founded by Rohini Kalvakuntla in 2021.
Who are Helex's investors?
Helex's investors include pi Ventures, SOSV, IndieBio.
How much funding has Helex raised?
Helex has disclosed $3.5M raised across 1 of its 2 known rounds.